Accès à distance ? S'identifier sur le proxy UCLouvain
Frequency of circulating Tregs with demethylated FOXP3 intron 1 in melanoma patients receiving tumor vaccines and potentially Treg-depleting agents.
Primary tabs
Document type | Article de périodique (Journal article) – Article de recherche – Journal Article, Research Support, Non-U.S. Gov't |
---|---|
Access type | Accès restreint |
Publication date | 2011 |
Language | Anglais |
Journal information | "Clinical Cancer Research" - Vol. 17, no. 4, p. 841-8 (2011) |
Peer reviewed | yes |
issn | 1078-0432 |
Publication status | Publié |
Affiliation | UCL - SSS/DDUV - Institut de Duve |
MESH Subject | Antibodies, Monoclonal - therapeutic use ; Antineoplastic Agents - therapeutic use ; Humans ; Immunoglobulin G - therapeutic use ; Interleukin-2 - therapeutic use ; Introns ; Lymphocyte Depletion ; Male ; Melanoma - immunology, pathology, therapy ; Recombinant Fusion Proteins - therapeutic use ; Retrospective Studies ; T-Lymphocytes, Regulatory - metabolism, pathology ; Cancer Vaccines - therapeutic use ; Cell Count ; Cyclophosphamide - therapeutic use ; DNA Methylation ; Diphtheria Toxin - therapeutic use ; Female ; Forkhead Transcription Factors - genetics ; Genetic Markers - genetics |
Links |
Bibliographic reference | de Vries, I Jolanda M ; Castelli, Chiara ; Huygens, Caroline ; Jacobs, Joannes F M ; Stockis, Julie ; et. al. Frequency of circulating Tregs with demethylated FOXP3 intron 1 in melanoma patients receiving tumor vaccines and potentially Treg-depleting agents.. In: Clinical Cancer Research, Vol. 17, no. 4, p. 841-8 (2011) |
---|---|
Permanent URL | http://hdl.handle.net/2078/88219 |